From February 5, 2024 to March 31, 2024, the company has repurchased 2,070,000 shares, representing 1.08% for CNY 12.98 million. With this, the company has completed the repurchase of 2,070,000 shares, representing 1.08% for CNY 12.98 million under the buyback announced on February 6, 2024.
Thalys Medical Technology Group Corporation
Equities
603716
CNE1000030C3
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7.27 CNY | +6.13% | +16.69% | -34.45% |
1st Jan change | Capi. | |
---|---|---|
-34.45% | 181M | |
-3.54% | 9.4B | |
+31.91% | 1.92B | |
-2.51% | 1.39B | |
-5.95% | 1.18B | |
-16.69% | 856M | |
+0.53% | 470M | |
+3.39% | 437M | |
-47.20% | 360M | |
-22.36% | 333M |
- Stock Market
- Equities
- 603716 Stock
- News Thalys Medical Technology Group Corporation
- Tranche Update on Thalys Medical Technology Group Corporation's Equity Buyback Plan announced on February 6, 2024.